Log in
Enquire now
Virpax Pharmaceuticals Inc.

Virpax Pharmaceuticals Inc.

Our product candidates are being developed to manage global unmet needs in the areas of cancer and non-cancer pain, PTSD, and CNS Disorder.

OverviewStructured DataIssuesContributors

Contents

virpaxpharma.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Neuroscience
Neuroscience
Psychology
Psychology
Market research
Market research
Pharmaceutical industry
Pharmaceutical industry
Life science
Life science
Therapeutics
Therapeutics
Biopharma
Biopharma
...
Location
Berwyn, Pennsylvania
Berwyn, Pennsylvania
CEO
‌
Anthony P. Mack
Pitchbook URL
pitchbook.com/profiles...227401-03
Legal Name
Virpax Pharmaceuticals, Inc.
Number of Employees (Ranges)
1 – 10
Email Address
info@virpaxpharma.com
Phone Number
+16107274597
Full Address
1055 Westlakes Drive, Suite 300 | Berwyn, PA 19312
1055 Westlakes Drive, Suite 300 Berwyn, PA 19312, USA
1055 Westlakes Drive, Suite 300 Berwyn, PA 19312
CIK Number
1,708,3310
Place of Incorporation
Delaware
Delaware
0
DUNS Number
0807683180
IRS Number
821,510,9820
Founded Date
2017
Stock Symbol
VRPX0
Exchange
Nasdaq
Nasdaq
Board of Directors
‌
Thani Jambulingam
‌
Dr. Eric Floyd
‌
Jerrold Sendrow
‌
Gary S. Jakob
Vanila M. Singh
Vanila M. Singh
‌
Michael F. Dubin
‌
Jeffrey Gudin
‌
Gerald W. Bruce
CFO
Christopher M. Chipman
Christopher M. Chipman
Also Known As
VRPX
CAGE Code
88EA60
Country
United States
United States

Other attributes

Company Operating Status
Active
SIC Code
2,8340
Ticker Symbol
VRPX

Our mission is to improve widely used and newly developed non-addictive pain medicines, PTSD, and neurological disorder product candidates for worldwide commercialization.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Altasciences and Virpax conduct first-in-human study of chronic pain

Megan Thomas

https://www.ddw-online.com/altasciences-and-virpax-conduct-first-in-human-study-for-chronic-pain-15534-202201/

Web

January 28, 2022

FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids for Acute Pain Management

https://www.fda.gov/news-events/press-announcements/fda-takes-steps-aimed-fostering-development-non-addictive-alternatives-opioids-acute-pain-management

Web

February 9, 2022

Virpax AngelMD Video

https://youtu.be/Qq_VV-UEG70

Web

March 4, 2019

Virpax Reports Favorable Preclinical Safety Data for EnveltaTM for the Treatment of Acute and Chronic Pain

Business Wire

https://finance.yahoo.com/news/virpax-reports-favorable-preclinical-safety-140000992.html

Web

February 10, 2022

References

Find more companies like Virpax Pharmaceuticals Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.